Daniel was a Glaxo graduate student in the Department of Surgery, University College London. Following the completion of his PhD in 1994 (UCL) he joined Professor Hugh Perry, then in Oxford, on a British Biotech fellowship investigating metalloproteinase expression in the CNS. During this period he also held a position as retained lecturer at Trinity College Oxford (1994-1998). Daniel joined the Pharmacology Department at the University of Oxford as Associate Professor in 2004 from Southampton University (1998-2004). In 2015 he was awarded a personal Chair in Experimental Neuropathology. Daniel is also adjunct Professor of Neurobiology at SDU, Denmark and holds a chaire d’excellence at the University of Lille. The strategy he pursues combines state-of-the-art MRI and PET imaging with and molecular biology and immuno techniques to discover how inflammation contributes to CNS injury and disease.